145 related articles for article (PubMed ID: 38070023)
1. Expression of Pivotal Long Non-coding RNAs Implicated in Gastric Cancer: A Bioinformatic and Clinical Study.
Mohammadi R; Zareh A; Rabani E; Kheirandish Zarandi P; Khoncheh A; Heiat M
Biochem Genet; 2023 Dec; ():. PubMed ID: 38070023
[TBL] [Abstract][Full Text] [Related]
2. Expression assessment of a panel of long non-coding RNAs in gastric malignancy.
Esfandi F; Salehnezhad T; Taheri M; Afsharpad M; Hafez AA; Oskooei VK; Ghafouri-Fard S
Exp Mol Pathol; 2020 Apr; 113():104383. PubMed ID: 31982396
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of C5orf66-AS1 as a Potential Biomarker for Predicting Early Gastric Cancer and Its Role in Gastric Carcinogenesis.
Zhou Q; Li H; Jing J; Yuan Y; Sun L
Onco Targets Ther; 2020; 13():2795-2805. PubMed ID: 32308414
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA OIP5-AS1 promotes cell proliferation and aerobic glycolysis in gastric cancer through sponging miR-186.
Huang J; Hou S; Xu J; Wu J; Yin J
Arch Med Sci; 2021; 17(6):1742-1751. PubMed ID: 34900056
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA FEZF1-AS1 indicates a poor prognosis of gastric cancer and promotes tumorigenesis via activation of Wnt signaling pathway.
Wu X; Zhang P; Zhu H; Li S; Chen X; Shi L
Biomed Pharmacother; 2017 Dec; 96():1103-1108. PubMed ID: 29239821
[TBL] [Abstract][Full Text] [Related]
6. Expression and clinical significance of long non-coding RNA HNF1A-AS1 in human gastric cancer.
Dang Y; Lan F; Ouyang X; Wang K; Lin Y; Yu Y; Wang L; Wang Y; Huang Q
World J Surg Oncol; 2015 Oct; 13():302. PubMed ID: 26472090
[TBL] [Abstract][Full Text] [Related]
7. Integrative analysis of the gastric cancer long non-coding RNA-associated competing endogenous RNA network.
Jiang Y; Zhang X; Rong L; Hou Y; Song J; Zhang W; He M; Xie Y; Li Y; Song F
Oncol Lett; 2021 Jun; 21(6):456. PubMed ID: 33907566
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA OIP5-AS1 aggravates cell proliferation, migration in gastric cancer by epigenetically silencing NLRP6 expression via binding EZH2.
Bai Y; Li S
J Cell Biochem; 2020 Jan; 121(1):353-362. PubMed ID: 31219209
[TBL] [Abstract][Full Text] [Related]
9. Identification of HCG18 and MCM3AP-AS1 That Associate With Bone Metastasis, Poor Prognosis and Increased Abundance of M2 Macrophage Infiltration in Prostate Cancer.
Chen Y; Chen Z; Mo J; Pang M; Chen Z; Feng F; Xie P; Yang B
Technol Cancer Res Treat; 2021; 20():1533033821990064. PubMed ID: 33596783
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA OIP5-AS1 promotes the growth of gastric cancer through the miR-367-3p/HMGA2 axis.
Tao Y; Wan X; Fan Q; Wang Y; Sun H; Ma L; Sun C; Wu Y
Dig Liver Dis; 2020 Jul; 52(7):773-779. PubMed ID: 31959478
[TBL] [Abstract][Full Text] [Related]
11. The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer.
Ke D; Li H; Zhang Y; An Y; Fu H; Fang X; Zheng X
Oncotarget; 2017 Mar; 8(13):21516-21525. PubMed ID: 28423525
[TBL] [Abstract][Full Text] [Related]
12. Circulating long noncoding RNA, Zfpm2-As1, and XIST based on medical data analysis are potential plasma biomarkers for gastric cancer diagnosis.
Liang H; Li H; Xia N; Chen J; Gao L; Liu H; Lyu P; Guo X; Yang Z
Technol Health Care; 2024 May; ():. PubMed ID: 38820035
[TBL] [Abstract][Full Text] [Related]
13. lncRNAs dysregulation in monocytes from primary antiphospholipid syndrome patients: a bioinformatic and an experimental proof-of-concept approach.
Guzmán-Martín CA; Juárez-Vicuña Y; Domínguez-López A; González-Ramírez J; Amezcua-Guerra LM; Martínez-Martínez LA; Sánchez-Muñoz F
Mol Biol Rep; 2023 Jan; 50(1):937-941. PubMed ID: 36367661
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic significance of long noncoding RNA SSTR5-AS1 in patients with gastric cancer.
Cheng Y; Di J; Wu J; Shi HT; Zou BC; Zhang Y; Xie DH
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5385-5390. PubMed ID: 32495873
[TBL] [Abstract][Full Text] [Related]
15. LncRNA FGD5-AS1 drives the malignant development of gastric cancer by negatively interacting with FZD3.
Feng L; Zheng H; Zhang H; Cao M; Zhou H
Pol J Pathol; 2022; 73(1):72-79. PubMed ID: 35848483
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA OIP5-AS1 promotes proliferation of gastric cancer cells by targeting miR-641.
Wang LW; Li XB; Liu Z; Zhao LH; Wang Y; Yue L
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10776-10784. PubMed ID: 31858545
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of the clinical roles of the VHL-related LncRNAs in clear cell renal cell carcinoma.
Yang W; Zhou J; Zhang K; Li L; Xu Y; Ma K; Xie H; Cai L; Gong Y; Gong K
J Cancer; 2021; 12(9):2702-2714. PubMed ID: 33854630
[TBL] [Abstract][Full Text] [Related]
18. Silencing of Long Non-Coding RNA-HCG18 Inhibits the Tumorigenesis of Gastric Cancer Through Blocking PI3K/Akt Pathway.
Ma F; An K; Li Y
Onco Targets Ther; 2020; 13():2225-2234. PubMed ID: 32256081
[TBL] [Abstract][Full Text] [Related]
19. Moderate Prognostic Value of lncRNA FOXD2-AS1 in Gastric Cancer with Helicobacter pylori Infection.
Rajabi A; Bastani S; Maydanchi M; Tayefeh-Gholami S; Abdolahi S; Saber A; Safaralizadeh R
J Gastrointest Cancer; 2022 Sep; 53(3):687-691. PubMed ID: 34478035
[TBL] [Abstract][Full Text] [Related]
20. Expression levels and associations of five long non-coding RNAs in gastric cancer and their clinical significance.
Binang HB; Wang YS; Tewara MA; Du L; Shi S; Li N; Nsenga AGA; Wang C
Oncol Lett; 2020 Mar; 19(3):2431-2445. PubMed ID: 32194743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
